galantamine has been researched along with caproctamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Bartolini, M; Bolognesi, ML; Cavalli, A; Mancini, F; Melchiorre, C; Micco, M; Milelli, A; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Bolognesi, ML; Cavalli, A; Melchiorre, C | 1 |
1 review(s) available for galantamine and caproctamine
| Article | Year |
|---|---|
Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease.
Topics: Alkanes; Alzheimer Disease; Amides; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anisoles; Antioxidants; Aspartic Acid Endopeptidases; Attention; Choline; Drug Design; Ethylamines; Galantamine; Humans; Memory; Neurons; Phosphorylation; Plaque, Amyloid; Platelet Aggregation Inhibitors; tau Proteins | 2009 |
1 other study(ies) available for galantamine and caproctamine
| Article | Year |
|---|---|
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Cholinesterase Inhibitors; Drug Design; Ligands; Molecular Structure; Polyamines; Stereoisomerism; Structure-Activity Relationship | 2008 |